Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Science6 min read

GLP-1 Medications and Mental Health: What We Know So Far

Emerging research shows GLP-1 medications may affect mood, anxiety, and addictive behaviors. Here's what the science says - and what patients are reporting.

Updated September 15, 2026

Medically reviewed on

How we review

Beyond Weight Loss: GLP-1 Receptors in the Brain

A mug of tea, a closed journal and a folded blanket on a sunlit windowsill beside a plant, a calm scene about mood and GLP-1 medication
GLP-1 receptors aren't just found in the gut and pancreas - they're widely distributed throughout the brain, including areas involved in reward processing, emotional regulation, and decision-making. This has led researchers to investigate whether GLP-1 medications might have neuropsychiatric effects beyond appetite suppression. Early findings are intriguing: some studies suggest potential benefits for mood, anxiety, and addictive behaviors, while questions remain about the full scope of these effects.

Our top 2 picks

Our two recommended GLP-1 providers, shown with the same verified pricing and ratings as our full comparison.

Our Top Pick
1
embody logo

Exceptional

9.8out of 10

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Free expedited deliveryNo hidden fees
  • Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
  • Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
  • Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
  • No insurance required, no clinic visits; cancel at least 72 hours before the next billing date

from $49/month

Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required.

Read full embody review
2
altRx logo

Excellent

9.4out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required
  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.

Read full altRx review

What Patients Are Reporting

Anecdotal reports from patients on semaglutide and tirzepatide frequently describe changes that go beyond reduced appetite. Many report decreased interest in alcohol, reduced urge to engage in compulsive behaviors (gambling, shopping, scrolling), and what some describe as quieting of obsessive thoughts about food.

Some patients report improved mood and reduced anxiety, while a smaller number describe feeling emotionally flat or experiencing mild depressive symptoms. These reports are consistent enough to have prompted formal research, though individual experiences vary widely.

The Addiction and Reward Connection

Some of the most compelling emerging research involves GLP-1 medications and addictive behaviors. Several studies have shown reduced alcohol consumption in patients taking semaglutide, and clinical trials are now underway examining its potential for treating alcohol use disorder, nicotine dependence, and opioid addiction.

The proposed mechanism involves GLP-1 receptors in the brain's reward circuitry - the same pathways involved in food cravings. By modulating dopamine signaling in these areas, GLP-1 medications may reduce the reinforcing effects of various addictive substances and behaviors.

Shop GLP-1 plans by product

The lowest published plans - cheapest first, conditions under each price.

Depression and Anxiety Research

The relationship between GLP-1 medications and mood disorders is complex. Weight loss itself often improves depression and anxiety symptoms - better body image, improved mobility, and reduced inflammation all contribute to mental health improvements.

Separating these indirect effects from direct neurological effects of the medication is challenging. However, some preclinical studies suggest that GLP-1 receptor activation has anti-inflammatory effects in the brain and may influence serotonin and dopamine pathways directly.

Clinical trials specifically examining these psychiatric applications are ongoing but early-stage.

What To Know Before Starting GLP-1 Treatment

Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.

GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.

That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.

Woman preparing GLP-1 weight loss injection

Potential Concerns

Not all reported mental health effects are positive. A subset of patients reports emotional blunting - a reduced ability to feel pleasure or emotional range - which some attribute to the medication's effects on reward pathways.

There have also been post-marketing reports of suicidal ideation, though regulatory reviews by the FDA and EMA have not established a causal link. Patients with a history of depression, eating disorders, or other mental health conditions should discuss these considerations with their provider before starting treatment and report any mood changes promptly.

For a broader look at side effect management, see our side effects guide.

What This Means for You

If you're taking or considering GLP-1 medication, be aware that mental health effects - both positive and negative - are possible. Monitor your mood, energy, and emotional state, especially during the first few months and after dose changes.

If you notice improvements in areas like alcohol consumption or compulsive behaviors, that's consistent with what many patients experience. If you notice persistent low mood, emotional numbness, or any concerning psychological changes, contact your provider.

Choosing a provider with strong clinical oversight matters - learn what to look for or find your match through our quiz.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)